Intensive Care Patient Articles & Analysis
15 news found
Particular support for decolonisation of pathogens which is the approach taken by its XF-73 Nasal programme Destiny Pharma plc (AIM: DEST), a clinical stage innovative biotechnology company focused on the development of novel medicines that can prevent life-threatening infections, today reports on the publication of findings from the US Food and Drug Administration (FDA) and US Centers for ...
N8 Medical, LLC (N8 Medical) today announced its first-in-human clinical trials of its flagship CeraShield™ endotracheal tube (CeraShield™ ETT) for intensive care unit patients expected to require mechanical ventilation for more than 48 hours. ...
Researchers in London, Ont., are the first in the world to use a new device for feeding tube insertion that can improve patient safety and reduce the cost of health-care services. A team from Lawson Health Research Institute has partnered with CoapTech LLC, a medical device company, to study the use of the PUMA-G System. ...
ByCoapTech
Antimicrobial resistance (AMR) takes a huge toll on a nation's economy and its health system, prolonging hospital stays, leading to the need for more expensive intensive care, and reducing the productivity of patients or their caregivers. ...
The idea: Use of the antimicrobial and tissueregenerating effect of cold plasma in medicine and care with a small, handy device for stationary and mobile use. In 2019 the plasma care® was approved for the treatment of chronic wounds, in 2021 the plasma derma care® for the treatment of skin diseases induced by bacteria and fungi. The ...
Christon Hill, Vice President for Product Life Cycle Management, said: “There is an acute need for reliable rescue therapy for toxic methotrexate concentration in patients with delayed clearance due to impaired renal function. As we continue to achieve regulatory milestones that broaden the availability of glucarpidase globally, we grow more excited for Voraxaze’s ...
General hospital wards have been noted for having limited capacity to respond to rapidly-deteriorating patients compared to intensive care units due to the difficulty of constant patient monitoring. In-hospital cardiac arrest, with a high mortality rate of 75%[i], strikes over 290,000 hospital patients each year ...
Ramirez, an emergency physician in Toronto, “By using the device (AGM100), we are sending fewer patients to the Intensive Care Unit, and we have higher confidence that those sent to the ICU really need to be there. Far more patients can be evaluated and treated at much less cost and time.” He is not alone. ...
In less than two minutes, it allows doctors to assess how well a patient’s lungs are taking oxygen from the air through their lungs into the bloodstream,” says Dr. ...
The medical device enables rapid, repeatable, and trusted hemodynamic assessments throughout the continuum of care, including emergency department and intensive care unit patients with COVID-19. ...
She has specific experience in respiratory monitoring technologies and an education and clinical background in intensive care patient management. “We are delighted to welcome Laura Piccinini as RMI’s CEO” commented Chas Taylor, Chairman of RMI. ...
The foundation of our next generation system is an integrated artificial lung cartridge/blood pump that will be unparalleled in the industry as the most efficient carbon dioxide removal and oxygen delivery system, which will address the needs of acute respiratory failure patients that require ECCO2R and/or ECMO (extracorporeal membrane oxygenation). ...
Once again Yaguo have made a donation in order to support the frontline of the epidemic, helping with their innovating products that brings out intensive care and rehabilitation. On March 7th, YAGUO sent to Hubei a new set of respiratory devices, the number goes up to 100 devices worth around 2.2 million RMB, including bionic cough simulator (sputum removal ...
Healthcare facility should use dedicated or disposable noncritical patient-care equipment (e.g., blood pressure cuffs). If equipment is to be used for more than one patient, clean and disinfect such equipment before use. ...
C. auris is a highly virulent and lethal pathogen of key clinical concern in hospitals and particularly among patients in the intensive care unit (ICU). As many of these patients are already seriously ill, C. auris can have an estimated mortality rate as high as 60% internationally. ...